# I PREVENT - Irbesartan In Hypertensive Diabetic Patients

> **NCT00362258** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 797 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Irbesartan (Aprovel)

## Key facts

- **NCT ID:** NCT00362258
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 797 (ACTUAL)
- **Last updated:** 2011-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362258, "I PREVENT - Irbesartan In Hypertensive Diabetic Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00362258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*